Navigation Links
MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers
Date:12/2/2010

NOVATO, Calif., Dec. 2, 2010 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has completed review of the Clinical Trial Application (CTA) and has issued a notice of acceptance for BMN 673 for genetically-defined cancers.  The company expects to initiate a Phase 1/2 trial by the first quarter of 2011.

"BMN 673 has been proven to be highly active in mouse xenograft models of human cancer and appears to have superior potency, selectivity, and bioavailability as compared to other products in development," said Hank Fuchs, Chief Medical Officer of BioMarin.  "We are eager to get this trial underway and to identify specific tumor types that are more susceptible to treatment with BMN 673.  We have built a deep R&D pipeline and remain focused on successfully and expeditiously executing on the programs."

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase)
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Arbor Pharmaceuticals Completes $34.8 Million Financing
2. Aires Pharmaceuticals, Inc. Completes $20M Equity Financing and Signs an Option Agreement with a Major Pharmaceutical Company
3. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
4. Apollo Endosurgery Completes First-in-Human Cases With New OverStitch™ Endoscopic Suturing System
5. Boston Scientific Completes Acquisition of Asthmatx
6. Warner Chilcott Completes Acquisition of U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
7. Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therapy
8. Incept BioSystems Completes First Human Clinical Trial of the SMART Start™ Embryo Culture System and Submits 510(k) Application to the FDA
9. InfraReDx Completes $21 Million Equity Financing
10. Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
11. Apollo Endosurgery Completes First Clinical Case with Newly-Launched FlexShears™ Endoscopic Scissors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... LUXEMBOURG , May 17, 2013  ConvaTec today announced that it ... Ken Berger , CEO, and Ed Borkowski ... AM ET live via telephone. To participate in the ... (877) 366-0267. To participate in the conference call outside the ... The conference ID is 72195398. Participants should dial in ...
(Date:5/17/2013)... MIAMI LAKES, Fla. , May 17, 2013 ... products and delivery technology company that is developing new, patent-pending ... and minerals, announced today that it will hold a business ... on Wednesday, May 22 nd , 2013 at 4:30 PM ... Brian Tuffin will host the call and will ...
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... Kyle Guse , Chief Financial Officer & ... MicroCap Conference on Thursday, May 30, 2013, in ... The Company,s presentation is scheduled to begin ... live webcast. To access the webcast, go to www.atossagenetics.com ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3
(Date:5/19/2013)... 20, 2013 California has one of the ... employers are quickly discovering that comprehensive background checks are playing ... job. Driving records can paint an accurate ... that person has any DUI arrests, speeding offenses, and traffic ... are lining up to experience 4SafeDrivers.com, a new online service ...
(Date:5/19/2013)... new measure of the heterogeneity the variety of genetic ... treatment outcomes of patients with the most common type of ... of the journal Cancer , investigators at Massachusetts General ... their measure was a better predictor of survival than most ... squamous cell carcinoma of the head and neck. ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Cheap Concert ... his two concerts in Vegas in October will go on ... during the spring and summer months of 2013, this legendary ... , Whenever people hear “It’s Five O’clock Somewhere” ... voice of Jimmy Buffett inside their heads. Fortunately, fans can ...
(Date:5/19/2013)... A leading symptom of peripheral neuropathy, the ... end through natural ways, such as Neuracel’s Ultimate Support ... number of different underlying problems, the most commonly diagnosed ... is characterized by damage to the peripheral nerves in ... larger system, the peripheral nervous system. The peripheral nervous ...
(Date:5/19/2013)... HealthDay Reporter , , SATURDAY, May 18 (HealthDay News) ... Crohn,s disease overcome the fatigue and decreased muscle ... to new research. Extra vitamin D "was ... fatigue, greater quality of life and the ability ... Raftery, a research dietitian and doctoral candidate at ...
Breaking Medicine News(10 mins):Health News:4SafeDrivers.com Announces Driving Record Searches for California Employers 2Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 2Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 3Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 2Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 3Health News:Peripheral Neuropathy Naturally Treatable Through Neuracel's Ultimate Neuropathy Support System 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3
... ARBOR, Mich., March 2 /PRNewswire/ -- The ... VHA Inc., the national healthcare alliance, as its preferred ... this preferred vendor designation, Thomson Reuters is authorized to ... members nationwide. Clinical Xpert has been named the KLAS ...
... OnlineHARRISBURG, Pa., March 2 United Concordia has enhanced ... tool and the service is now available online at ... a comprehensive redesign and now enables users to locate ... obtain driving directions to the dentist,s office. In addition ...
... the forthcoming 24th Annual EAU Congress in Stockholm (SE), the ... Studio. A first in the organisation,s annual congresses, EAU TV ... live in the EAU TV area at the congress venue ... start with a short introduction on the topic and continue ...
... one in every 2500 live births. Bones in the skulls ... of distressing developmental problems. Some of the affected children also ... Depending on the severity of their disease and its underlying ... a few days to as long as early adulthood. ...
... Reasons; Integrated Retention Strategy and Senior Management Commitment Are Necessary,to ... ... Orlando, FL (Vocus) March 2, 2009 -- Market ... bad news for health insurance providers. The good news: properly ...
... Health Care Associates, Inc. (MHA), the largest Alternate Site ... new website www.mhainc.com . The site was redesigned ... strong brand and leadership standing in the healthcare market. ... core businesses and supporting services, view current news announcements, ...
Cached Medicine News:Health News:VHA Selects Clinical Xpert from Thomson Reuters as its Preferred Solution for Mobile Clinical Improvement Systems 2Health News:VHA Selects Clinical Xpert from Thomson Reuters as its Preferred Solution for Mobile Clinical Improvement Systems 3Health News:United Concordia Dental Enhances Its Web-Based Find a Dentist Tool 2Health News:EAU TV goes 'live' at 24th Annual EAU Congress in Stockholm 2Health News:Common Approaches to Member Retention by Health Insurance Plans are Ineffective, New Study Shows 2Health News:Common Approaches to Member Retention by Health Insurance Plans are Ineffective, New Study Shows 3Health News:MHA Announces: Launch of New Website 2
... fully automated high-throughput glass-on-glass coverslipper. The ... microscope glass slides bearing tissue sections ... quality-grade coverslips of different standard sizes ... capability of handling a large variety ...
... mountant media dispensing system eliminates ... under the coverglass. All new ... most automated staining machines. Available ... pre-filled coverglass and mountant dispensers. ...
... Trellis Infusion Catheter enables the physician to ... fluid, and disperse the agent by means ... Trellis is a multi-lumen catheter with two ... and infusion holes located between these balloons. ...
ACRYSOF®, Posterior Chamber Intraocular Lenses are indicated for the replacement of the human lens to achieve visual correction of aphakia in patients sixty years and older. These lenses are i...
Medicine Products: